{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.158G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T substitution"
        },
        {
          "HGVS": "NM_001126112.3:c.260G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "260"
          },
          "Protein Change": {
            "ref": "S",
            "alt": "N",
            "position": "87"
          },
          "Description in input context": "S87N substitution"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005258"
  },
  "Experiment Method": [
    {
      "Assay Method": "Fluorescence Analysis",
      "Material used": {
        "Material Source": "Chimeric proteins (human-mouse α-synuclein variants)",
        "Material Name": "Human/mouse SNCA chimeras",
        "Description": "Fluorescence analysis of chimeric α-synuclein proteins to assess lag times and growth kinetics."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.158G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Dominant effect on growth kinetics",
          "Result Description": "A53T substitution significantly altered growth kinetics compared to wild-type."
        },
        {
          "Variant": "NM_001126112.3:c.260G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Modulatory effect on lag phase",
          "Result Description": "S87N substitution contributed to lag phase abnormalities when combined with A53T."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Not explicitly described in the literature.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Not explicitly described in the literature.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "NMR Chemical Shift Analysis",
      "Material used": {
        "Material Source": "Chimeric proteins (human-mouse α-synuclein variants)",
        "Material Name": "Human/mouse SNCA chimeras",
        "Description": "NMR analysis of chimeric α-synuclein proteins to assess secondary structure propensities."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.158G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered secondary structure",
          "Result Description": "A53T substitution induced conformational changes in secondary structure."
        },
        {
          "Variant": "NM_001126112.3:c.260G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Modulatory effect on secondary structure",
          "Result Description": "S87N substitution influenced secondary structure propensities in combination with A53T."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D.",
        "Description": "Not explicitly described in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Not explicitly described in the literature.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Not explicitly described in the literature.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}